Health
Decipher Test Clinically Validated as a Predictor of Overall Survival in Men with Prostate Cancer – PRNewswire
/PRNewswire/ — Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, with a focus in urologic oncology…
SAN DIEGO, Feb. 11, 2021 /PRNewswire/ — Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, with a focus in urologic oncology specific to prostate and bladder cancers, today announced publication of the results, in JAMA Oncology, from an analysis of the NRG Oncology Phase 3 randomized controlled trial RTOG 96-01. In this study, the Decipher Prostate RP, a radical prostatectomy post-surgery test, was clinically validated to predict overall survival…
Continue Reading
